14-104724461-AGGTGCGGGCTGGGGCGCCG-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_152328.5(ADSS1):c.192+3_192+21del variant causes a splice donor, splice donor 5th base, coding sequence, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000016 in 1,247,256 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 9.1e-7 ( 0 hom. )
Consequence
ADSS1
NM_152328.5 splice_donor, splice_donor_5th_base, coding_sequence, intron
NM_152328.5 splice_donor, splice_donor_5th_base, coding_sequence, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.24
Genes affected
ADSS1 (HGNC:20093): (adenylosuccinate synthase 1) This gene encodes a member of the adenylosuccinate synthase family of proteins. The encoded muscle-specific enzyme plays a role in the purine nucleotide cycle by catalyzing the first step in the conversion of inosine monophosphate (IMP) to adenosine monophosphate (AMP). Mutations in this gene may cause adolescent onset distal myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.16957788 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADSS1 | NM_152328.5 | c.192+3_192+21del | splice_donor_variant, splice_donor_5th_base_variant, coding_sequence_variant, intron_variant | 1/13 | ENST00000330877.7 | NP_689541.1 | ||
ADSS1 | XM_006720026.4 | c.192+3_192+21del | splice_donor_variant, splice_donor_5th_base_variant, coding_sequence_variant, intron_variant | 1/14 | XP_006720089.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADSS1 | ENST00000330877.7 | c.192+3_192+21del | splice_donor_variant, splice_donor_5th_base_variant, coding_sequence_variant, intron_variant | 1/13 | 1 | NM_152328.5 | ENSP00000331260 | P1 | ||
ADSS1 | ENST00000710323.1 | c.192+3_192+21del | splice_donor_variant, splice_donor_5th_base_variant, coding_sequence_variant, intron_variant | 1/13 | ENSP00000518203 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151894Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
151894
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 9.13e-7 AC: 1AN: 1095362Hom.: 0 AF XY: 0.00000193 AC XY: 1AN XY: 518228
GnomAD4 exome
AF:
AC:
1
AN:
1095362
Hom.:
AF XY:
AC XY:
1
AN XY:
518228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151894Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74190
GnomAD4 genome
AF:
AC:
1
AN:
151894
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74190
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 04, 2024 | Variant summary: ADSS1 c.-5428_-5410del19 is located in the untranscribed region upstream of the ADSS1 gene region (NM_199165). However, this variant can be interpreted as c.192+3_192+21del in NM_152328. Computational tools predict this variant may impact the splicing of NM_152328 transcript: two predict that this variant abolishes a 5' splice donor site and two predict that this variant weakens a 5' splice donor site. The variant was absent in 31260 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.-5428_-5410del19 in individuals affected with Myopathy, Distal, 5 and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined aboe, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at